Altered muscle membrane potential and redox status differentiates two subgroups of patients with chronic fatigue syndrome.
Jammes, Yves, Adjriou, Nabil, Kipson, Nathalie et al. · Journal of translational medicine · 2020 · DOI
Quick Summary
This study examined muscle function and stress markers in 72 ME/CFS patients during rest, exercise, and recovery. Researchers found that about half the patients showed significant changes in how their muscles respond to electrical signals, combined with higher levels of oxidative stress (cellular damage from chemical imbalance). The other half showed normal muscle responses and lower stress markers. This suggests ME/CFS may include at least two different biological subtypes.
Why It Matters
This study provides objective biomarkers (muscle membrane excitability and oxidative stress measurements) that could help identify subgroups within ME/CFS, potentially explaining why patients respond differently to treatments. If confirmed, these findings could enable more precise diagnosis and tailored treatment strategies based on individual biological profiles rather than symptom patterns alone.
Observed Findings
Approximately 54% of ME/CFS patients (39/72) demonstrated marked M-wave alterations during and after exercise in both tested muscles.
Patients with M-wave alterations had significantly elevated resting levels of oxidative stress markers (TBARS and ORP).
Patients with M-wave alterations showed decreased potassium efflux during exercise compared to the other subgroup.
M-wave changes were inversely proportional to oxidative stress marker levels (higher stress associated with more muscle changes).
33 patients showed normal M-wave patterns with lower baseline oxidative stress levels despite meeting ME/CFS diagnostic criteria.
Inferred Conclusions
ME/CFS comprises at least two biochemically distinct subgroups with different patterns of muscle membrane excitability and oxidative stress.
Altered muscle membrane excitability at rest in roughly half of ME/CFS patients may reflect underlying oxidative stress affecting resting muscle function.
Oxidation-reduction potential (ORP) measurement may improve diagnostic specificity and could help stratify patients for treatment selection.
Remaining Questions
Do these two biomarker subgroups represent distinct disease mechanisms or different stages of the same disease process?
What This Study Does Not Prove
This study does not establish causation—it shows correlation between oxidative stress and muscle membrane changes but cannot prove which causes which or if both result from another process. The findings are observational in a single cohort and lack healthy control groups, so it remains unclear whether these biomarkers are specific to ME/CFS or represent general muscle dysfunction. The study does not test whether correcting oxidative stress would improve muscle function or clinical symptoms.